Noted: But that didnâ??t deter Stinchcomb or his co-founder, Jorge Osorio, a professor at the University of Wisconsin-Madison School of Veterinary Medicine who grew up in Colombia, where dengue fever is endemic. Inviragen lined up $250,000 in angel funding and some grants from the National Institutes of Health, and initial animal trials of Inviragenâ??s vaccine were soon showing promising results. Even Schwarzer started to believe that this could be a compelling business proposal.
Office of Strategic Communication